NDB
NDB is a selective human FXRα (hFXRα) antagonist that is effective in modulating transcription of FXRα downstream genes. NDB can be used in anti-diabetes research[1].
Product Specifications
CAS Number
[1660153-08-1]
UNSPSC
12352005
Target
FXR
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/ndb.html
Purity
98.36
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N(C1=CC=C(O)C(C(C)(C)C)=C1)CC2=CC=CC=C2)C3=C(Cl)C=C(N(C)C)C=C3Cl
Molecular Formula
C26H28Cl2N2O2
Molecular Weight
471.42
References & Citations
[1]Xing Xu, et al. Structural Basis for Small Molecule NDB (N-Benzyl-N- (3- (tert-butyl) -4-hydroxyphenyl) -2,6-dichloro-4- (dimethylamino) Benzamide) as a Selective Antagonist of Farnesoid X Receptor α (FXRα) in Stabilizing the Homodimerization of the Receptor. J Biol Chem. 2015 Aug 7;290 (32) :19888-99.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6505387-01 0.2 mL
USP33, CT (Ubiquitin Carboxyl-terminal Hydrolase 33, Ubiquitin Thiolesterase 33, Ubiquitin-specific Processing Protease 33, Deubiquitinating Enzyme 33, VHL-interacting Deubiquitinating Enzyme 1, hVDU1, KIAA1097, VDU1) (AP)
Ask
View Details MBS6505387-02 5x 0.2 mL
USP33, CT (Ubiquitin Carboxyl-terminal Hydrolase 33, Ubiquitin Thiolesterase 33, Ubiquitin-specific Processing Protease 33, Deubiquitinating Enzyme 33, VHL-interacting Deubiquitinating Enzyme 1, hVDU1, KIAA1097, VDU1) (AP)
Ask
View Details MBS6359427-01 0.1 mL
TSEN2, NT (TSEN2, SEN2, tRNA-splicing endonuclease subunit Sen2, tRNA-intron endonuclease Sen2) (MaxLight 650)
Ask
View Details